Nailfold digital capillaroscopy in 447 patients with connective tissue disease and Raynaud's disease

Journal of the European Academy of Dermatology and Venereology

Volumn 18, Issue 1, 2004, Pages 62-68

  Nagy, Z ^a   Czirják, Laszlo ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Nailfold capillaroscopy; Raynaud's phenomenon; Scleroderma; Systemic sclerosis; Undifferentiated connective tissue disease

Indexed keywords

ADULT; ARTICLE; CAPILLAROSCOPY; CAPILLARY DENSITY; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DERMATOMYOSITIS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DIGITAL COMPUTER; DISEASE CLASSIFICATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; POLYMYOSITIS; PRIORITY JOURNAL; RAYNAUD PHENOMENON; RHEUMATOID ARTHRITIS; SCLERODERMA; SIGNAL PROCESSING; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ADULT; CAPILLARIES; CHI-SQUARE DISTRIBUTION; CONNECTIVE TISSUE DISEASES; DERMATOMYOSITIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MICROSCOPY; MIDDLE AGED; NAILS; RAYNAUD DISEASE; SCLERODERMA, SYSTEMIC; VASCULAR DISEASES;

EID: 0842264994     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2004.00853.x     Document Type: Article

References (59)

1. Kabasakal Y, Elvins DM, Ring EF, McHugh NJ. Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis 1996; 55(8): 507-512.
2. LeRoy EC, Medsger TA Jr. Raynaud's phenomenon: a proposal for classification. Clin Exp Rheumatol 1992; 10(5): 485-488.
3. FitzGerald O, Hess EV, O'Connor GT, Spencer Green G. Prospective study of the evolution of Raynaud's phenomenon. Am J Med 1988; 84(4): 718-726.
4. Gerbracht DD, Steen VD, Ziegler GL et al. Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease. Arthritis Rheum 1985; 28(1): 87-92.
5. Priollet P, Vayssairat M, Housset E. How to classify Raynaud's phenomenon. Long-term follow-up study of 73 cases [published erratum appears in Am J Med 1987; 83(6): A11]. Am J Med 1987; 83(3):494-498.
6. McGill NW, Gow PJ. Nailfold capillaroscopy: a blinded study of its discriminatory value in scleroderma, systemic lupus erythematosus, and rheumatoid arthritis. Aust N Z J Med 1986; 16(4): 457-460.
7. Houtman PM, Kallenberg CG, Fidler V, Wouda AA. Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon. An analysis of patterns discriminating patients with and without connective tissue disease. J Rheumatol 1986; 13(3): 556-563.
8. Ohtsuka T, Ishikawa H. Statistical definition of nail fold capillary pattern in patients with systemic sclerosis [see comments]. Dermatology 1994; 188(4): 286-289.
9. ter Borg EJ, Piersma Wichers G, Smit AJ et al. Serial nailfold capillary microscopy in primary Raynaud's phenomenon and scleroderma. Semin Arthritis Rheum 1994; 24(1): 40-47.
10. Planchon B, Pistorius MA, Beurrier P, De Faucal P. Primary Raynaud's phenomenon. Age of onset and pathogenesis in a prospective study of 424 patients. Angiology 1994; 45(8): 677-686.
11. Maricq HR, Harper FE, Khan MM et al. Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease. Clin Exp Rheumatol 1983; 1(3): 195-205.
12. Maricq HR, LeRoy EC, D'Angelo WA et al. Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum 1980; 23: 183-189.
13. Ubbink DT, Janssen HA, Schreurs MM, Jacobs MJ. Capillary microscopy is a diagnostic aid in patients with acral ischemia. Angiology 1995; 46(1): 59-64.
14. Monticone G, Colonna L, Palermi G et al. Quantitative nailfold capillary microscopy findings in patients with acrocyanosis compared with patients having systemic sclerosis and control subjects. J Am Acad Dermatol 2002; 42(5 Part 1): 787-790.
15. Harper FE, Maricq HR, Turner RE et al. A prospective study of Raynaud phenomenon and early connective tissue disease. A five-year report. Am J Med 1982; 72: 883-888.
16. Luggen M, Belhorn L, Evans T et al. The evolution of Raynaud's phenomenon: a longterm prospective study. J Rheumatol 1995; 22(12): 2226-2232.
17. Zufferey P, Depairon M, Chamot AM, Monti M. Prognostic "significance of nailfold capillary microscopy in patients with Raynaud's phenomenon and scleroderma-pattern abnormalities. A six-year follow-up study. Clin Rheumatol 1992; 11(4): 536-541.
18. Scheja A, Akesson A, Niewierowicz I et al. Computer based quantitative analysis of capillary abnormalities in systemic sclerosis and its relation to plasma concentration of von Willebrand factor. Ann Rheum Dis 1996; 55(1): 52-56.
19. Ganczarczyk ML, Lee P, Armstrong SK. Nailfold capillary microscopy in polymyositis and dermatomyositis. Arthritis Rheum 1988; 31(1): 116-119.
20. Blockmans D, Beyens G, Verhaeghe R. Predictive value of nailfold capillaroscopy in the diagnosis of connective tissue diseases. Clin Rheumatol 1996; 15(2): 148-153.
21. Groen H, Wichers G, ter Borg EJ et al. Pulmonary diffusing capacity disturbances are related to nailfold capillary changes in patients with Raynaud's phenomenon with and without an underlying connective tissue disease. Am J Med 1990; 89(1): 34-41.
22. Ohtsuka T, Yamakage A, Tamura T. Image analysis of nailfold capillaries in patients with undifferentiated connective tissue syndromes. J Dermatol 1995; 22(12): 921-925.
23. Saban J, Rodriguez Garcia JL, Pais JR et al. Raynaud's phenomenon with digital necrosis as the first manifestation of undifferentiated connective tissue syndrome. Dermatologica 1991; 182(2): 121-123.
24. Ohtsuka T, Tamura T, Yamakage A, Yamazaki S. The predictive value of quantitative nailfold capillary microscopy in patients with undifferentiated connective tissue disease. Br J Dermatol 1998; 139(4): 622-629.
25. Ohtsuka T. Quantitative analysis of nailfold capillary abnormalities in patients with connective tissue diseases [in process citation]. Int J Dermatol 1999; 38(10): 757-764.
26. Wollersheim H, Thien T, Hoet MH, Van Venrooy WJ. The diagnostic value of several immunological tests for anti-nuclear antibody in predicting the development of connective tissue disease in patients presenting with Raynaud's phenomenon. Eur J Clin Invest 1989; 19(6): 535-541.
27. Lefford F, Edwards JC. Nailfold capillary microscopy in connective tissue disease: a quantitative morphological analysis. Ann Rheum Dis 1986; 45(9): 741-749.
28. Lee P, Leung FY, Alderdice C, Armstrong SK. Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment. J Rheumatol 1983; 10(6): 930-938.
29. Granier F, Vayssairat M, Priollet P, Housset E. Nailfold capillary microscopy in mixed connective tissue disease. Comparison with systemic sclerosis and systemic lupus erythematosus. Arthritis Rheum 1986; 29(2): 189-195.
30. Redisch W, Messina EJ, Hughes G, McEwen C. Capillaroscopic observations in rheumatic diseases. Ann Rheum Dis 1970; 29(3): 244-253.
31. Anders HJ, Haedecke C, Sigl T, Kruger K. Avascular areas on nailfold capillary microscopy of patients with Wegener's granulomatosis. Clin Rheumatol 2000; 19(2): 86-88.
32. Masi A, Rodnan G, Medsger T. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980; 23: 581-590.
33. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292: 344-347.
34. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975; 292: 403-407.
35. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
36. Kumanovics G, Zibotics H, Juhasz E et al. Subclinical pulmonary involvement assessed by bronchoalveolar lavage in patients with early undifferentiated connective tissue disease. Clin Exp Rheumatol 2001; 19(5): 551-559.
37. Maricq HR. Wide-field capillary microscopy. Arthritis Rheum 1981; 24: 1159-1165.
38. Lovy M, MacCarter D, Steigerwald JC. Relationship between nailfold capillary abnormalities and organ involvement in systemic sclerosis. Arthritis Rheum 1985; 28(5): 496-501.
39. Maricq HR. Patterns of finger capillary abnormalities in connective tissue disease by 'wide-field' microscopy. Arthritis Rheum 1973; 16: 619-628.
40. Cervini C, Grassi W. Raynaud phenomenon. Rheum Eur 1996; 25(3): 111-113.
41. LeRoy EC, Black C, Fleischmajer R et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15(2): 202-205.
42. Alarcon GS, Williams GV, Singer JZ et al. Early undifferentiated connective tissue disease. I. Early clinical manifestation in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of well established connective tissue disease. J Rheumatol 1991; 18(9): 1332-1339.
43. Clegg DO, Williams HJ, Singer JZ et al. Early undifferentiated connective tissue disease. II. The frequency of circulating antinuclear antibodies in patients with early rheumatic diseases. J Rheumatol 1991; 18(9): 1340-1343.
44. LeRoy EC, Maricq HR, Kahaleh MB. Undifferentiated connective tissue syndromes. Arthritis Rheum 1980; 23(3): 341-343.
45. Mosca M, Tavoni A, Neri R et al. Undifferentiated connective tissue diseases: the clinical and serological profiles of 91 patients followed for at least 1 year [see comments]. Lupus 1998; 7(2): 95-100.
46. Calvo Alen J, Alarcon GS, Burgard SL et al. Systemic lupus erythematosus: predictors of its occurrence among a cohort of patients with early undifferentiated connective tissue disease: multivariate analyses and identification of risk factors. J Rheumatol 1996; 23(3): 469-475.
47. Danieli MG, Fraticelli P, Salvi A et al. Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD [in process citation]. Clin Rheumatol 1998; 17(3): 195-201.
48. Bulpitt KJ, Clements PJ, Lachenbruch PA et al. Early undifferentiated connective tissue disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis). Ann Intern Med 1993; 118(8): 602-609.
49. Williams HJ, Alarcon GS, Joks R et al. Early undifferentiated connective tissue disease (CTD). VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well established and undifferentiated CTD. J Rheumatol 1999; 26(4): 816-825.
50. Danieli MG, Fraticelli P, Franceschini F et al. Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases [in process citation]. Clin Exp Rheumatol 1999; 17(5): 585-591.
51. Alarcon GS, Willkens RE, Ward JR et al. Early undifferentiated connective tissue disease. IV. Musculoskeletal manifestations in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of patients with well-established connective tissue diseases: followup analyses in patients with unexplained polyarthritis and patients with rheumatoid arthritis at baseline. Arthritis Rheum 1996; 39(3): 403-414.
52. Williams HJ, Alarcon GS, Neuner R et al. Early undifferentiated connective tissue disease. V. An inception cohort 5 years later: disease remissions and changes in diagnoses in well established and undifferentiated connective tissue diseases. J Rheumatol 1998; 25(2): 261-268.
53. Maricq HR, Spencer Green G, LeRoy EC. Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud's syndrome and dermatomyositis. Am J Med 1976; 61: 862-870.
54. Pallis M, Hopkinson N, Powell R. Nailfold capillary density as a possible indicator of pulmonary capillary loss in systemic lupus erythematosus but not in mixed connective tissue disease [see comments]. J Rheumatol 1991; 18(10): 1532-1536.
55. Borg EJ, Groen H, Horst G et al. Clinical associations of antiribonucleoprotein antibodies in patients with systemic lupus erythematosus. Semin Arthritis Rheum 1990; 20(3): 164-173.
56. Jouanny P, Schmidt C, Feldmann L, Schmitt J. Capillaroscopie peri-ungueale. Interet dans le diagnostic des maladies systemiques. Presse Med 1993; 22(27): 1256-1260.
57. Tektonidou M, Kaskani E, Skopouli FN, Moutsopoulos HM. Microvascular abnormalities in Sjogren's syndrome: nailfold capillaroscopy. Rheumatology (Oxford) 1999; 38(9): 826-830.
58. Carpentier P, Franco A. Capillaroscopie et phenomene de Raynaud. J Mal Vasc 1984; 9(1): 23-28.
59. Kallenberg CG, Wouda AA, Hoet MH, van Venrooij WJ. Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting. Ann Rheum Dis 1988; 47(8): 634-641.